According to the clinical data, secondhand smoke kills 42,000 Americans every year, including nearly 900 infants. Secondhand smoke is linked to some of the same fatal illnesses caused by smoking, including lung cancer, SIDS (sudden infant death syndrome), respiratory distress syndrome and so on.

Previously, a study conducted by the Centers for Disease Control and Prevention (CDC) also measured the health and economic impacts of secondhand smoking. As a whole, smoking greatly influences people’s health from the long term. Particularly, the incidence of lung cancer is increasing rapidly in recent years and has become one of main causes of death. Therefore, people with a history of smoking should better smoke fewer cigarettes and give up smoking if it is possible. On one hand, the harmful substances in the cigarettes will impair the smokers’ body. On the other hand, the smoke will also do great harm to the people around the smokers.

If one is diagnosed with lung cancer, he or she should receive an appropriate treatment as soon as possible. And a specialized personal treatment plan also plays an important role in the prognosis of lung cancer. If the patients’ condition is a little complex and weak, there is also an alternative therapy for lung cancer. As a new kind of therapy for cancer, cell-based immunotherapy emerged in recent years and it has obtained satisfactory therapeutic effects. In the first place, it can eliminate the residual cancer cells in the body without damaging the normal cells. That is to say, this kind of therapy will not influence the patients’ normal immune system and the patients suffer less from the treatment. Secondly, cell-based immunotherapy can improve the patients’ immunity and improve their quality of life from the long term. In general, cell-based immunotherapy is a good choice for the treatment of lung cancer.

Patients with non-small-cell lung cancer survive longer if they are taking beta-blockers while receiving radiotherapy, According to a study published in the journal Annals of Oncology, if patients with non-small-cell lung cancer take beta-blockers during the course of radiotherapy, they can survive longer.

As we all know, radiotherapy is a conventional treatment method for lung cancer and widely applied in clinic. However, the therapeutic effect of simplex radiotherapy is not as good as expected. Consequently, the doctors usually suggest that radiotherapy should be combined with other supportive treatment methods in the treatment of lung cancer. The researchers find that 155 patients who administrate on beta-blockers for other conditions, such as high blood pressure and heart disease, survive for an average of 23.7 months compared to the 567 patients who are not on beta-blockers. The mechanism of metastases is complex, but may involve chronic stress conditions and prolonged exposure to stress hormones. One of these hormones, norepinephrine, has been shown to stimulate the migration of tumor cells to other parts of the body. Receptors on the surface of cells, which beta-blockers are designed to inhibit, are involved in this process. Therefore, the application of beta-blockers can obviously prolong the patients’ survival time.

Apart from that, there is also another alternative option for the treatment of lung cancer. In recent years, cell-based immunotherapy emerged as the latest and effective treatment method for cancer. Furthermore, its significant therapeutic effect has been acknowledged by a great number of patients with lung cancer. In the first place, it can effectively eliminate the residual cancer cells in the body without damaging the normal cells. In that case, the reoccurrence rate of lung cancer will reduce obviously. Secondly, cell-based immunotherapy can reverse the drug-resistance and make the patients more sensitive to chemotherapy or radiotherapy. Apart from that, if cell-based immunotherapy is combined with chemotherapy or radiotherapy, the patients with lung cancer will survive longer and their quality of life will improve a lot.

On the basis of the data from National Cancer Institute, the incidence of lung cancer is the highest in recent few years. Besides, some researchers pointed out that the five-year survival rate can be as high as 80% for patients with lung cancer at early stage. Consequently, early detection plays an important role in the prognosis of pancreatic cancer. Then, it is absolutely necessary for us to get acknowledge of some common symptoms of lung cancer at early stage.

Persistent coughing

As we all know, cough can be associated with many relevant factors, including catching a cold, allergic reaction, dry air and so on. However, when the cough persists for a few weeks, it may be a sign of something else. Apart from that, for patients with asthma or gastroesopahgeal reflux, they may tend to ignore it. Hemoptysis is also a common symptom of lung cancer, but you can only notice a small amount of blood tinged phlegm. Therefore, if you suffer from a persistent cough, you should make a consultation with your doctor.

Pain

It is well known that pain is usually a common symptom of lung cancer for that the tumor of the lung may compress the nerves and further contribute to chest pain, back pain, and so on. Besides, it is estimated that 50% of the patients with lung cancer suffered from chest pain and shoulder pain, which will worsen with coughing and breathing.

Recurrent episodes of infectious diseases

For patients with bronchitis or pneumonia, they can also develop lung cancer after several episodes of these diseases. If the tumor is located near the airway, the obstruction of the airway will predispose you to these infections. Therefore, if you experienced repeated infections, you should go the hospital and talk with your doctor.

Abdominal symptoms and a general decline in health

With the development of industry and the change of people’ living habits, the incidence of lung cancer is increasing significantly in recent years all over the world. Generally speaking, the symptoms of lung cancer are not so obvious that many people tend to ignore them in daily life. As a result, nearly 40% of people with lung cancer have metastases to a distant region of the body at the time of diagnosis. Then, what can you expect if your lung cancer has spread to your lung?

In the first place, you should confirm that whether your lung cancer has spread to your liver. On general, you may not experience any symptoms at all. On the other hand, if you do have some symptoms, these may include pain under your ribs on the right side of your body and some general symptoms, such as loss of appetite and nausea. Then, if the metastatic tumor in the liver is large enough to obstruct your bile ducts, jaundice may develop eventually. However, you can go to the hospital to receive some examinations on condition that there is absence of some symptoms, including CT scan of the abdomen, abdominal ultrasound, MRI of the abdomen, PET scan and so on.

For patients with liver metastasis, the treatment should be mild and has fewer side effects. To every one’s joy, cell-based immunotherapy emerged as a new kind of effective treatment method for lung cancer with liver metastasis for that it has obvious advantages over these traditional methods. Compared with chemotherapy and radiotherapy, cell-based immunotherapy does not have any side effects and most patients can tolerate and respond well to it. Secondly, it can be applied to effectively kill the residual cancer cells in the body and eliminate some small lesions. Furthermore, it can be combined with traditional Chinese medicine to improve the patients’ quality of life and strengthen their immunity so that they can better fight against cancer from the long term. Apart from that, cell-based immunotherapy can also be combined with other treatment methods as a supportive treatment at early stage, including surgery, chemotherapy and radiotherapy. As a whole, for lung cancer patients with liver metastasis, cell-based immunotherapy may be a good choice.